← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Atlantic International Corp. (ATLN) 10-Year Financial Performance & Capital Metrics

ATLN • • Industrial / General
HealthcareDiagnostics & ResearchLife Sciences Instrumentation & ToolsNext-Generation Sequencing Platforms
AboutAs of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provides solutions for various applications, such as biomarker discovery and diagnostic assay developments, including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and Weizmann Institute of Science for developed and applied innovative single-molecule technologies. The company was formerly known as SeqLL Inc. and changed its name to Atlantic International Corp. in June 2024. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.Show more
  • Revenue $443M +10.3%
  • EBITDA -$17M -1161.5%
  • Net Income -$135M -788.3%
  • EPS (Diluted) -3.68 -513.3%
  • Gross Margin 10.66% -8.7%
  • EBITDA Margin -3.81% -1062.6%
  • Operating Margin -4.93% -473.7%
  • Net Margin -30.61% -705.5%
  • ROE -
  • ROIC -19.05% -293.8%
  • Debt/Equity -
  • Interest Coverage -1.82 -824.2%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 283.6%
  • ✓Efficient asset utilization: 3.6x turnover

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 11 (bottom 11%)
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Shares diluted 44.7% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y283.56%
3Y1.36%
TTM3.76%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM-39.77%

EPS CAGR

10Y-
5Y-
3Y-
TTM14.55%

ROCE

10Y Avg-515.59%
5Y Avg-230.31%
3Y Avg-4.21%
Latest-85.62%

Peer Comparison

Next-Generation Sequencing Platforms
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
BNGOBionano Genomics, Inc.15.47M1.52-0.02-14.79%-134.36%-77.49%0.77
ATLNAtlantic International Corp.135.19M2.31-0.6310.27%-22.66%
ILMNIllumina, Inc.22.2B145.30-18.89-2.93%16.4%29.53%3.19%1.10

Profit & Loss

Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+939.68K1.34M779.07K533.13K329.5K425.03M441.54M401.37M442.61M
Revenue Growth %-0.42%-0.42%-0.32%-0.38%1288.95%0.04%-0.09%0.1%
Cost of Goods Sold+520.1K1.08M674.28K219.76K170.8K370.62M387.34M354.5M395.43M
COGS % of Revenue0.55%0.81%0.87%0.41%0.52%0.87%0.88%0.88%0.89%
Gross Profit+419.59K254.23K104.79K313.37K158.69K54.41M54.21M46.88M47.18M
Gross Margin %0.45%0.19%0.13%0.59%0.48%0.13%0.12%0.12%0.11%
Gross Profit Growth %--0.39%-0.59%1.99%-0.49%341.85%-0%-0.14%0.01%
Operating Expenses+1.8M1.78M2.51M2.6M1.11M90.14M48.23M50.33M69.01M
OpEx % of Revenue1.92%1.33%3.22%4.89%3.36%0.21%0.11%0.13%0.16%
Selling, General & Admin690.98K806.9K1.47M1.36M777.43K42.18M42.27M45.44M64.02M
SG&A % of Revenue0.74%0.6%1.88%2.55%2.36%0.1%0.1%0.11%0.14%
Research & Development1.11M974.53K1.04M1.25M330.98K0000
R&D % of Revenue1.19%0.73%1.33%2.34%1%----
Other Operating Expenses0000047.96M5.96M4.89M4.99M
Operating Income+-1.39M-1.53M-2.4M-2.29M-949.72K-35.73M5.98M-3.45M-21.83M
Operating Margin %-1.47%-1.14%-3.08%-4.3%-2.88%-0.08%0.01%-0.01%-0.05%
Operating Income Growth %--0.1%-0.57%0.05%0.59%-36.62%1.17%-1.58%-5.33%
EBITDA+-1.34M-1.45M-2.34M-2.17M-840.96K-31.62M11.04M1.59M-16.84M
EBITDA Margin %-1.42%-1.09%-3%-4.07%-2.55%-0.07%0.03%0%-0.04%
EBITDA Growth %--0.09%-0.61%0.07%0.61%-36.6%1.35%-0.86%-11.61%
D&A (Non-Cash Add-back)48.86K72.64K63.64K121.53K108.76K4.11M5.07M5.04M4.99M
EBIT-1.38M-1.53M-2.66M-2.29M-758.15K8.07M6.87M-3.6M-118.1M
Net Interest Income+0-179.74K-230.3K-182.25K-287.2K-171.83K-45.87K-17.54M-12M
Interest Income0000036.46K44.88K00
Interest Expense50.74K179.74K230.3K182.25K287.2K208.29K90.75K17.54M12M
Other Income/Expense-49.13K-179.74K-486.73K-182.25K-95.63K-3.73M-8.39M-17.73M-108.27M
Pretax Income+-1.43M-1.71M-2.89M-2.47M-1.05M-39.46M-2.41M-21.18M-130.1M
Pretax Margin %-1.53%-1.28%-3.71%-4.64%-3.17%-0.09%-0.01%-0.05%-0.29%
Income Tax+-24-4001.33M808.43K-5.93M5.38M
Effective Tax Rate %1%1%1%1%1%1.03%1.34%0.72%1.04%
Net Income+-1.43M-1.71M-2.89M-2.47M-1.05M-40.8M-3.22M-15.25M-135.48M
Net Margin %-1.53%-1.28%-3.71%-4.64%-3.17%-0.1%-0.01%-0.04%-0.31%
Net Income Growth %--0.19%-0.69%0.14%0.58%-38.03%0.92%-3.74%-7.88%
Net Income (Continuing)-1.43M-1.71M-2.89M-2.47M-1.05M-40.8M-3.22M-15.25M-135.48M
Discontinued Operations000000000
Minority Interest000000000
EPS (Diluted)+-0.09-0.11-0.14-0.12-0.05-0.17-0.17-0.60-3.68
EPS Growth %--0.2%-0.27%0.14%0.59%-2.47%0%-2.53%-5.13%
EPS (Basic)-0.09-0.11-0.14-0.12-0.05-0.17-0.19-0.60-3.68
Diluted Shares Outstanding15.58M15.58M21.35M21.35M21.35M21.69M24.14M25.42M36.78M
Basic Shares Outstanding15.58M15.58M21.35M21.35M21.35M21.69M21.69M25.42M36.78M
Dividend Payout Ratio---------

Balance Sheet

Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+1.59M860.98K1.02M428.14K342.54K10.42M6.64M78.8M88.02M
Cash & Short-Term Investments207.25K30.06K64.69K5.86K09.95M6.22M1.35M678.68K
Cash Only207.25K30.06K64.69K5.86K04.02M2.18M1.35M678.68K
Short-Term Investments000005.93M4.04M00
Accounts Receivable246.77K44.91K236.61K135.67K139.53K65.68K81.21K64.48M73.44M
Days Sales Outstanding95.8512.24110.8592.88154.560.060.0758.6460.56
Inventory1.13M783.57K720.5K284.26K203.01K224.16K165.85K00
Days Inventory Outstanding796.5263.72390.02472.12433.830.220.16--
Other Current Assets00000003.68M4.7M
Total Non-Current Assets+273.51K218.53K156.06K460.26K351.5K315.75K1.78M47.87M34.73M
Property, Plant & Equipment251.53K189.97K126.33K446K337.24K265.27K1.66M2.8M2.38M
Fixed Asset Turnover3.74x7.05x6.17x1.20x0.98x1602.28x266.02x143.28x186.32x
Goodwill000000000
Intangible Assets000000036.19M31.4M
Long-Term Investments000000000
Other Non-Current Assets21.99K28.56K29.73K14.26K14.26K50.49K118.95K3.64M960.6K
Total Assets+1.87M1.08M1.18M888.4K694.04K10.74M8.41M126.67M122.75M
Asset Turnover0.50x1.24x0.66x0.60x0.47x39.57x52.48x3.17x3.61x
Asset Growth %--0.42%0.09%-0.25%-0.22%14.47%-0.22%14.05%-0.03%
Total Current Liabilities+1.72M2.83M575.98K1.22M1.01M2.56M1.23M161.56M97.25M
Accounts Payable167.8K214.85K451.53K897.66K861.84K871.36K622.44K799.57K2.03M
Days Payables Outstanding117.7672.31244.421.49K1.84K0.860.590.821.87
Short-Term Debt1M2.26M6.5K28K26K1.38M0138.9M43.88M
Deferred Revenue (Current)431.79K113.76K20.38K25K00000
Other Current Liabilities122.55K216.82K73.86K243.4K00360.46K011.1M
Current Ratio0.93x0.30x1.78x0.35x0.34x4.08x5.40x0.49x0.91x
Quick Ratio0.27x0.03x0.53x0.12x0.14x3.99x5.27x0.49x0.91x
Cash Conversion Cycle774.6203.65256.45-925.9-1.25K-0.58-0.36--
Total Non-Current Liabilities+303.97K8.47K990.71K2.5M3.54M02.82M4.46M37.52M
Long-Term Debt297.96K0990.71K2.5M3.54M01.38M980.85K36.71M
Capital Lease Obligations0000001.44M1.3M813.74K
Deferred Tax Liabilities000000000
Other Non-Current Liabilities6.02K8.47K000002.18M0
Total Liabilities2.03M2.83M1.57M3.72M4.55M2.56M4.05M166.02M134.77M
Total Debt+1.3M2.26M997.21K2.52M3.56M1.38M2.93M142.62M82.72M
Net Debt1.09M2.23M932.52K2.52M3.56M-2.64M748.93K141.26M82.04M
Debt / Equity-----0.17x0.67x--
Debt / EBITDA------0.27x89.88x-
Net Debt / EBITDA------0.07x89.03x-
Interest Coverage-27.30x-8.50x-10.43x-12.57x-3.31x-171.54x65.89x-0.20x-1.82x
Total Equity+-158.47K-1.75M-386.41K-2.83M-3.85M8.18M4.37M-39.35M-12.02M
Equity Growth %--10.07%0.78%-6.32%-0.36%3.12%-0.47%-10.01%0.69%
Book Value per Share-0.01-0.11-0.02-0.13-0.180.380.18-1.55-0.33
Total Shareholders' Equity-158.47K-1.75M-386.41K-2.83M-3.85M8.18M4.37M-39.35M-12.02M
Common Stock9090494949119119254531
Retained Earnings-2.6M-4.3M-7.19M-9.66M-10.71M-14.41M-18.51M-61.8M-135.48M
Treasury Stock000000000
Accumulated OCI-90-90-49-490022.45K00
Minority Interest000000000

Cash Flow

Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-2.15M-1.13M-1.78M-1.59M-757.91K-1.99M-3.66M-9.08M-5.99M
Operating CF Margin %-2.29%-0.84%-2.29%-2.97%-2.3%-0%-0.01%-0.02%-0.01%
Operating CF Growth %-0.48%-0.58%0.11%0.52%-1.63%-0.84%-1.48%0.34%
Net Income-1.43M-1.71M-2.89M-2.47M-1.05M-3.7M-4.09M-15.25M-135.48M
Depreciation & Amortization48.86K72.64K63.64K121.53K108.76K86.44K87.94K5.04M4.99M
Stock-Based Compensation00030.94K20.21K333.98K256.9K045.2M
Deferred Taxes0000000-5.14M5.24M
Other Non-Cash Items1.13M-408.7K829.31K182.25K286.97K1.17M242.81K6.07M58.11M
Working Capital Changes-859.4K395.22K232.44K553.5K-128.5K119.96K-155.38K204.34K15.95M
Change in Receivables-159.21K201.86K-191.7K100.94K-3.86K73.85K-15.54K-384.28K-9.92M
Change in Inventory-781.43K351.38K63.07K-4.96K81.25K-21.14K-20.71K00
Change in Payables0114.2K236.68K446.13K-35.82K9.52K-248.93K631.86K1.23M
Cash from Investing+-110.47K-11.08K000-5.99M1.83M-73.71K-73.46K
Capital Expenditures-110.47K-11.08K000-14.47K-40.02K-73.71K-73.46K
CapEx % of Revenue0.12%0.01%---0%0%0%0%
Acquisitions---------
Investments---------
Other Investing0000000-4.12M0
Cash from Financing+2.17M959.48K1.82M1.53M752.05K12M08.79M5.38M
Debt Issued (Net)---------
Equity Issued (Net)---------
Dividends Paid000000000
Share Repurchases---------
Other Financing00000-1.63M0-1.84M6.35M
Net Change in Cash---------
Free Cash Flow+-2.26M-1.14M-1.78M-1.59M-757.91K-2M-3.7M-9.16M-6.06M
FCF Margin %-2.41%-0.85%-2.29%-2.97%-2.3%-0%-0.01%-0.02%-0.01%
FCF Growth %-0.5%-0.57%0.11%0.52%-1.64%-0.85%-1.47%0.34%
FCF per Share-0.15-0.07-0.08-0.07-0.04-0.09-0.15-0.36-0.16
FCF Conversion (FCF/Net Income)1.50x0.66x0.62x0.64x0.73x0.05x1.14x0.60x0.04x
Interest Paid00000009.15M6.93M
Taxes Paid000000073.54K17.1K

Key Ratios

Metric201620172018201920202021202220232024
Return on Equity (ROE)------1885.23%-51.33%--
Return on Invested Capital (ROIC)-111.44%-163.02%-353.44%-1462.99%--1020.71%84.15%-4.84%-19.05%
Gross Margin44.65%18.99%13.45%58.78%48.16%12.8%12.28%11.68%10.66%
Net Margin-152.64%-127.5%-370.7%-463.97%-317.26%-9.6%-0.73%-3.8%-30.61%
Debt / Equity-----0.17x0.67x--
Interest Coverage-27.30x-8.50x-10.43x-12.57x-3.31x-171.54x65.89x-0.20x-1.82x
FCF Conversion1.50x0.66x0.62x0.64x0.73x0.05x1.14x0.60x0.04x
Revenue Growth-42.47%-41.81%-31.57%-38.2%128894.7%3.89%-9.1%10.27%

Frequently Asked Questions

Growth & Financials

Atlantic International Corp. (ATLN) reported $445.4M in revenue for fiscal year 2024. This represents a 47297% increase from $0.9M in 2016.

Atlantic International Corp. (ATLN) grew revenue by 10.3% over the past year. This is steady growth.

Atlantic International Corp. (ATLN) reported a net loss of $100.9M for fiscal year 2024.

Dividend & Returns

Atlantic International Corp. (ATLN) generated $3.3M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.